Effect of 17-β estradiol in the rabbit: Endothelium-dependent and - independent mechanisms of vascular relaxation

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 130-135

  Ma, Lianmin ^a   Robinson, Casey P ^b   Thadani, Udho ^a   Patterson, Eugene ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

17 Estradiol Nitric oxide Vasodilation

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ESTRADIOL; ESTROGEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ESTROGEN THERAPY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; AORTA, THORACIC; CALCIUM CHANNEL AGONISTS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; GUINEA PIGS; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; NITRIC OXIDE; VASCULAR RESISTANCE; VASODILATION;

EID: 0030667780     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00019     Document Type: Article

References (37)

1. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-43.
2. Mano T, Masuyama T, Yamamoto K, et al. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J 1996; 131:231-8.
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
4. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
5. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
6. Whittle BJ, Lopez-Belmonte J, Rees DD. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989;98:646-52.
7. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81:1680-7.
8. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991;104:1033-7.
9. Malinski T, Taha Z. Nitric oxide released from a single cell measured in situ by a porphyrin-based microsensor. Nature 1992;358: 676-8.
10. Tsukahara H, Gordienko DV, Goligorsky MS. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun 1993;193:722-9.
11. Engelman DT, Vatanabe M, Engelman RM, et al. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovas Surg 1995;110:1047-53.
12. Mayer B, Klatt P, Werner ER, Schmidt Kurt. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 1995;270:655-9.
13. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992;358: 676-8.
14. Shibuki K. An electrochemical microprobe for detecting nitric oxide release in brain tissue. Neurosci Res 1990;9:69-76.
15. Lin AL, Shain SA. Estrogen-mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis 1985;5:668-77.
16. Lin AL, Gonzalez R, Carey KD, Shain SA. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 1986;6:495-504.
17. Colburn P, Buonassisi V. Estrogen binding sites in endothelial cell cultures. Science 1978;201:817-9.
18. Katzenellenbogen BS, Ferguson ER. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen. Endocrinology 1975;97:1-12.
19. Batra S. Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes. Cancer Chemother Pharmacol 1990;26:310-2.
20. Raddino R, Poli E, Pela G, Manca C. Action of steroid sex hormones on the isolated rabbit heart. Pharmacology 1989;38:185-90.
21. Raddino R, Manca C, Poli E, Bolognesi R, Visioli O. Effects of 17β-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther 1986;281:57-65.
22. 2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels. Biol Reprod 1987; 37:361-8.
23. 2+ currents in aortic smooth muscle cells. Eur J Pharmacol 1995;294:625-35.
24. Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis 1995;6: 417-22.
25. Fabiato A, Fabiato F. Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat and frog hearts and from newborn rat ventricles. Ann NY Acad Sci 1978;307:491-522.
26. Bozler E. Role of calcium in initiation of activity of smooth muscle. Am J Physiol 1969;216:671-4.
27. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992;263:H271-5.
28. Highsmith RF, Pang DC, Rapoport RM. Endothelial cell-derived vasoconstrictors: mechanisms of action in vascular smooth muscle. J Cardiovasc Pharmacol 1989;13:S36-45.
29. 2 in porcine coronary artery. Circulation 1995;91:2619-26.
30. Amezcua JL, Dusting GL, Palmer RMJ, Moncada S. Acetylcholine induces vasodilation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br J Pharmacol 1988;95: 830-4.
31. Kelm M, Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol 1988;155:317-21.
32. Amezcua JL, Palmer RMJ, de Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1989;97:1119-23.
33. Smith REA, Palmer RMJ, Bucknall CA, Moncada S. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc Res 1992;26:508-12.
34. Engelman DT, Watanabe M, Engelman RM, et al. Constitative nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 1995;110:1047-53.
35. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-7.
36. Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994;90:1964-8.
37. Mügge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res 1993;27:1939-42.